Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant

American Journal of Hematology

Volumn 82, Issue 10, 2007, Pages 932-933

  Abidi, Muneer H ^a   Tove, Isaacson ^a   Ibrahim, Rami B ^a   Maria, Dan ^a   Peres, Edward ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; THALIDOMIDE; VINCRISTINE;

ADULT; ANASARCA; ARTICLE; CANCER RECURRENCE; CASE REPORT; CLINICAL FEATURE; CYTOGENETICS; DISEASE COURSE; FEMALE; FEVER; HEART PALPITATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATOSPLENOMEGALY; HISTIOCYTIC SARCOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHADENOPATHY; MENORRHAGIA; PANCYTOPENIA; PRIORITY JOURNAL; RASH; SARCOMA; SYMPTOM; THROMBOCYTE COUNT; WEIGHT REDUCTION;

ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DISEASE PROGRESSION; DOXORUBICIN; ETOPOSIDE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTIOCYTES; HUMANS; MIDDLE AGED; PREDNISONE; RETROPERITONEAL NEOPLASMS; SARCOMA; THALIDOMIDE; VINCRISTINE;

EID: 34848926930     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20913     Document Type: Article

References (8)

1. Jaffe ES, Harris NL, Stein H, Vardiman JW. Pathology and Genetics of Tumors of Hematopoietic and Lymphoid Tissue, Lyon: IARC Press; 2001.
2. Elghetany MT. True histiocytic lymphoma: Is it an entity? Leukemia 1997;11:762-764.
3. Vos JA, Abbondanzo SL, Barekman CL, Andriko JW, Miettinen M, Aguilera NS. Histiocytic sarcoma: A study of five cases including the histiocyte marker CD163. Mod Pathol 2005;18:693-704.
4. Teo SK. Properties of thalidomide and its analogues: Implications for anticancer therapy. AAPS J 2005;7:E14-E19.
5. Leleu X, Micol JB, Guieze R, Berthon C, Fuhnovisky F, Terriou L. Thalidomide: Mechanisms of action and new insights in hematology. Rev Med Intern 2005;26:119-127.
6. Pileri SA, Grogan TM, Harris NL, et al. Tumours of histiocytes and accessory dendritic cells: An immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 2002;41:1-29.
7. Sander CS, Kaatz M, Elsner P. Successful treatment of cutaneous Langerhans cell histiocytosis with thalidomide. Dermatology 2004;208:149-152.
8. Dalle JH, Leblond P, Decouvelaere A, Yakoub-Agha I, Preudhomme C, Nelken B. Efficacy of thalidomide in a child with histiocytic sarcoma following allogeneic bone marrow transplantation for T-ALL. Leukemia 2003;17:2056-2057.